logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
H

Hany Elmaraghy

Eli Lilly and Company

13H指数
56论文数
950被引数
收录论文 28
发表时间
logo
Correction: Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)更正：Lebrikizumab治疗中重度特应性皮炎的三年疗效与安全性：一项长期扩展研究（ADjoin）
errDermatology and Therapy
IF4.2
err2026-08-28
err0
errOAAI
errEmma Guttman-Yassky; Alan D. Irvine; Melinda Gooderham; Stephan Weidinger; Lynda Spelman; Jonathan I. Silverberg; Heidi Crane; Hany ElMaraghy; Louise DeLuca-Carter; Maria Lucia Buziqui Piruzeli; Georgia Martimianaki; Evangeline Pierce; Helena Agell; Diamant Thaçi
err分享
err收藏
Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitisLebrikizumab停药后缓解期可维持长达38周，见于特应性皮炎。
errJournal of Dermatological Treatment
IF3.9
err2026-03-12
err0
errOAAI
errJonathan I. Silverberg; Thomas Bieber; Kilian Eyerich; April W. Armstrong; Brian J. Nickoloff; Chitra R. Natalie; Gaia Gallo; Angela Okragly; Eric Wolf; Chenjia Xu; Brian A. Moser; Maria Jose Rueda; Hany Elmaraghy; Ozge Uluckan; Johann E. Gudjonsson
err分享
err收藏
361 Lebrikizumab Dosed Every 8 Weeks as Maintenance Provides Long-Lasting Response in Patients with Moderate-to-Severe Atopic Dermatitis361 勒布rikizumab 每8周作为维持剂量使用可为中重度特应性皮炎患者提供长效应答
errJournal of Investigative Dermatology
IF5.7
err2025-11-10
err0
PREAI
errJonathan Silverberg; Vivian Laquer; Peter Lio; Kim Papp; Alan Irvine; Andrew Blauvelt; Hany Elmaraghy; Louise DeLuca-Carter; Heidi Crane; Gaia Gallo; Evangeline Pierce; Yuxin Ding; Amy Paller; Lucia Vidal
err分享
err收藏
Comparative molecular analysis of IL-17A and IL-23 pathway inhibition in moderate-to-severe psoriasis: 4-week results from IXORA-R中重度银屑病中IL-17A与IL-23通路抑制的分子比较分析：IXORA-R研究4周结果
errJournal of Investigative Dermatology
IF5.7
err2025-08-15
err0
PREAI
errSandra Garcet; Lam C. Tsoi; Hong Hur; Andrew Blauvelt; Kim A. Papp; Bruce Konicek; Zhe Sun; Richard E. Higgs; Ernst R. Dow; David C. Gemperline; Gaia Gallo; Hany Elmaraghy; Brian J. Nickoloff; Venkatesh Krishnan; James G. Krueger; Johann E. Gudjonsson
err分享
err收藏
Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitisLebrikizumab可改善中重度特应性皮炎患者的头/颈/面部皮炎和红斑，且不会增加治疗 emergent 的头/颈/面部红斑相关不良事件。
errJournal of Dermatological Treatment
IF3.9
err2025-07-24
err0
errOAAI
errJenny E. Murase; Kilian Eyerich; Raj Chovatiya; H. Chih-ho Hong; Christine Bangert; Lindsay Strowd; Mette Deleuran; Amber Reck Atwater; Maria Jose Rueda; Hany Elmaraghy; Maria Lucia Buziqui Piruzeli; Ignasi Pau-Charles; Fan Emily Yang; Jinglin Zhong; Delphine Staumont-Sallé
err分享
err收藏
Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitisLebrikizumab与患者报告的症状改善和生活质量指标的改善相关，且这一关联在湿疹面积和严重程度指数（EASI）应答类别中均得到体现：来自针对中重度特应性皮炎患者开展的III期随机ADvocate1和ADvocate2研究的合并结果。
errJOURNAL OF DERMATOLOGICAL TREATMENT
IF3.9
err2025-01-06
err0
errOAAI
errAndrew Blauvelt; Leon Kircik; Todd Schlesinger; Evangeline Pierce; Russel Burge; Michael Behling; Amber Reck Atwater; Hany ElMaraghy; April Armstrong
err分享
err收藏
The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials
errJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
IF11.8
err2024-12-01
err0
PREAI
errGuttman-Yassky, Emma; Rosmarin, David; de Bruin-Weller, Marjolein; Weidinger, Stephan; Bieber, Thomas; Hong, H. Chih-ho; Elmaraghy, Hany; Atwater, Amber Reck; Pierce, Evangeline; Xu, Chenjia; Agell, Helena; Gil, Esther Garcia; Simpson, Eric
err分享
err收藏
EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2024-08-08
err0
PREAI
errSilverberg, Jonathan, I; Bieber, Thomas; Eyerich, Kilian; Armstrong, April W.; Nickoloff, Brian J.; Natalie, Chitra R.; Gallo, Gaia; Okragly, Angela; Xu, Chenjia; Moser, Brian; Rueda, Maria Jose; Elmaraghy, Hany; Uluckan, Ozge; Gudjonsson, Johann E.
err分享
err收藏
Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2024-08-08
err0
PREAI
errZirwas, Matthew J.; Boguniewicz, Mark; Rosmarin, David; Fuxench, Zelma Chiesa; Warren, Richard B.; Torres, Tiago; de Bruin-Weller, Marjolein; Dawson, Zach; Atwater, Amber Reck; Elmaraghy, Hany; Pierce, Evangeline; Bardolet, Laia; Zhong, Jinglin; Armstrong, April W.
err分享
err收藏
The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis
errDERMATOLOGY AND THERAPY
IF4.2
err2024-07-15
err1
errOAAI
errSoung, Jennifer; Laquer, Vivian; Merola, Joseph F.; Moore, Angela; Elmaraghy, Hany; Hu, Chaoran; Piruzeli, Maria Lucia Buziqui; Pierce, Evangeline; Gil, Esther Garcia; Jarell, Abel D.
err分享
err收藏
Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis
errDERMATOLOGY AND THERAPY
IF4.2
err2024-06-26
err1
errOAAI
errLio, Peter A.; Armstrong, April; Gutermuth, Jan; Nosbaum, Audrey; Sofen, Howard; Gil, Esther Garcia; Casillas, Marta; Chen, Sherry; Sun, Luna; Pierce, Evangeline; Elmaraghy, Hany; Dawson, Zach; Torres, Tiago
err分享
err收藏
Assessing Itch Severity: Content Validity and Psychometric Properties of a Patient-Reported Pruritus Numeric Rating Scale in Atopic Dermatitis
errADVANCES IN THERAPY
IF4
err2024-02-16
err3
errOAAI
errRams, Alissa; Baldasaro, Jessica; Bunod, Laurine; Delbecque, Laure; Strzok, Sara; Meunier, Juliette; Elmaraghy, Hany; Sun, Luna; Pierce, Evangeline
err分享
err收藏
Lebrikizumab does not impact vaccine-induced immune responses: results from a phase 3 study in adult patients with moderate-to-severe atopic dermatitis
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2024-02-07
err0
PREAI
errSoung, Jennifer; Laquer, Vivian; Merola, Joseph F.; Forman, Seth; Elmaraghy, Hany; Meskimen, Eric; Hu, Chaoran; Natalie, Chitra R.; Pierce, Evangeline; Torisu-Itakura, Hitoe; Gil, Esther Garcia; Jarell, Abel D.
err分享
err收藏
Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2024-02-07
err0
PREAI
errGuttman-Yassky, Emma; Weidinger, Stephan; Simpson, Eric; Gooderham, Melinda; Irvine, Alan; Spelman, Lynda; Silverberg, Jonathan; Elmaraghy, Hany; DeLuca-Carter, Louise; Piruzeli, Maria Lucia Buziqui; Hu, Chaoran; Yang, Fan Emily; Pierce, Evangeline; Bardolet, Laia; Thaci, Diamant
err分享
err收藏
Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2023-11-06
err6
errOAAI
errYosipovitch, Gil; Lio, Peter A.; Rosmarin, David; Serra-Baldrich, Esther; Legat, Franz J.; Casillas, Marta; Pierce, Evangeline; Liu, Zhuqing; Sun, Luna; Elmaraghy, Hany; Staender, Sonja
err分享
err收藏
Efficacy of lebrikizumab in patients who did not achieve protocol-defined criteria for response after initial 16 weeks of therapy
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2023-06-20
err0
PREAI
errGuttman-Yassky, Emma; Rosmarin, David; Thyssen, Jacob P.; Weidinger, Stephan; Bieber, Thomas; Elmaraghy, Hany; Atwater, Amber Reck; Pierce, Evangeline; Xu, Chenjia; Gimeno, Helena Agell; Simpson, Eric; Mourey, Robert J.
err分享
err收藏
Safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis: data from eight trials
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2023-06-20
err0
PREAI
errGold, Linda Stein; Thaci, Diamant; Thyssen, Jacob P.; Gooderham, Melinda; Laquer, Vivian; Natalie, Chitra R.; Zhao, Fangyi; Meskimen, Eric; ElMaraghy, Hany; Montmayeur, Sonia; Jimenez, Gemma; de Bruin-Weller, Marjolein
err分享
err收藏
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2023-06-20
err0
PREAI
errHebert, Adelaide; Flohr, Carsten; Hong, H. Chih-ho; Irvine, Alan; Pierce, Evangeline; Elmaraghy, Hany; Xu, Wen; Pillai, Sreekumar; Dawson, Zach; Siegfried, Elaine; Weidinger, Stephan
err分享
err收藏
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
errAMERICAN JOURNAL OF CLINICAL DERMATOLOGY
IF8.8
err2023-05-17
err15
errOAAI
errGold, Linda Stein; Thaci, Diamant; Thyssen, Jacob P.; Gooderham, Melinda; Laquer, Vivian; Moore, Angela; Natalie, Chitra R.; Zhao, Fangyi; Meskimen, Eric; Elmaraghy, Hany; Montmayeur, Sonia; Gallo, Gaia; Jimenez, Gemma; de Bruin-Weller, Marjolein
err分享
err收藏
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2023-03-30
err41
errOAAI
errBlauvelt, Andrew; Thyssen, Jacob P.; Guttman-Yassky, Emma; Bieber, Thomas; Serra-Baldrich, Esther; Simpson, Eric; Rosmarin, David; Elmaraghy, Hany; Meskimen, Eric; Natalie, Chitra R.; Liu, Zhuqing; Xu, Chenjia; Pierce, Evangeline; Morgan-Cox, MaryAnn; Gil, Esther Garcia; Silverberg, Jonathan, I
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
J
James G. Krueger
H 指数: 143 · 论文数: 746
C
C.E.M. Griffiths
H 指数: 131 · 论文数: 1.3K
M
Mark Lebwohl
H 指数: 120 · 论文数: 1.4K
E
Emma Guttman‐Yassky
H 指数: 115 · 论文数: 763
A
Alice B. Gottlieb
H 指数: 111 · 论文数: 863
查看更多